Acadian Asset Management

Acadian Asset Management’s Kalaris Therapeutics KLRS Stock Holding History

Acadian Asset Management’s Portfolio KLRS Stock Details KLRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$181K	Sell
2024 Q2	$850K	Sell
2024 Q1	$1.2M	Buy
2023 Q4	$134K	Buy